X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications

Monday, July 23, 2012

MENLO PARK, Calif., and LEUVEN, Belgium–(BUSINESS WIRE)–

Pacific Biosciences of California, Inc. (NASDAQ:PACB) provider of the

PacBio® RS High Resolution Genetic Analyzer and

Belgium-based nanoelectronics research center imec today announced a

multi-year research collaboration focused on the development of advanced

microchips for highly multiplexed single molecule genetic analysis. This

research and development project will build on Pacific Biosciences’

proprietary zero-mode waveguide (ZMW) technology and imec’s

world-leading expertise in nanophotonics, CMOS sensors, technology

integration and fabrication.

“From our inception we have been committed to exploiting the potential

of the unique capabilities of our ZMW-based Single Molecule, Real-Time

(SMRT®) analysis technology to drive innovation in the life

sciences,” said Michael Hunkapiller, President and Chief Executive

Officer of Pacific Biosciences. “The goal of this collaboration is to

harness the power of microchips to scale the capacity and throughput of

our SMRT technology. We look forward to working with imec on this

advanced development program as we continue to expand the application

space for our platform.”

Luc Van den hove, Chief Executive Officer and President of imec,

commented: “We are excited to work with the leading single molecule

sequencing company to identify ways to bring greater economies of scale

to this breakthrough technology through nanoscale semiconductor

fabrication. This collaboration is another example of how imec leverages

the research competencies of its Life Science Program with its CMORE

technology platforms to deliver full custom integrated nano/microsystem

solutions to our partners for new and emerging markets.”

For more information about Pacific Biosciences, please visit www.pacb.com,

or follow us on Twitter: https://twitter.com/pacbio.

About Pacific Biosciences
Pacific Biosciences of California,

Inc. (NASDAQ: PACB) offers the PacBio® RS High

Resolution Genetic Analyzer to help scientists solve genetically complex

problems. Based on its novel Single Molecule, Real-Time (SMRT®)

technology, the company’s products enable: targeted sequencing to more

comprehensively characterize genetic variations; de novo genome

assembly to more fully identify, annotate and decipher genomic

structures; and DNA base modification identification to help

characterize epigenetic regulation and DNA damage. By providing access

to genetic information that was previously inaccessible, Pacific

Biosciences enables scientists to increase their understanding of

biological systems.

About imec
Imec performs world-leading research in

nanoelectronics. Imec leverages its scientific knowledge with the

innovative power of its global partnerships in ICT, healthcare and

energy. Imec delivers industry-relevant technology solutions. In a

unique high-tech environment, its international top talent is committed

to providing the building blocks for a better life in a sustainable

society. Imec is headquartered in Leuven, Belgium, and has offices in

Belgium, the Netherlands, Taiwan, US, China, India and Japan. Its staff

of close to 2,000 people includes more than 600 industrial residents and

guest researchers. In 2011, imec’s revenue (P&L) was about 300 million

euro. Further information on imec can be found at www.imec.be.

Imec is a registered trademark for the activities of IMEC

International (a legal entity set up under Belgian law as a “stichting

van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish

Government), imec the Netherlands (Stichting IMEC Nederland, part of

Holst Centre which is supported by the Dutch Government), imec Taiwan

(IMEC Taiwan Co.) and imec China (IMEC Microelectronics

(Shanghai) Co. Ltd.) and imec India (Imec India Private Limited).

Media:
For Pacific BiosciencesNicole Litchfield, 415-793-6468
nicole@bioscribe.com
or
For

imecKatrien Marent, +32 474 30 28 66
katrien.marent@imec.be
or
Investors:
Pacific

BiosciencesTrevin Rard, 650-521-8450
ir@pacificbiosciences.com

Source: imec

News Provided by Acquire Media